Clinical Trials in Los Angeles

Showing 3141-3160 of 14,465 trials

International Rare Brain Tumor Registry

NCT05697874

The objective of the International Rare Brain Tumor Registry (IRBTR) is to better understand rare brain tumors through the collection of biospecimens and matched clinical data of children, adolescents, and young adult patients diagnosed with rare brain tumors.

AstroblastomaBCOR ITD SarcomaCNS Sarcoma+1 more

Children's National Research Institute5,800 participantsStarted Jan 2023

Los Angeles, California, United States • San Francisco, California, United States • Washington D.C., District of Columbia, United States +1 more locations

RECRUITING< 1 mile

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

NCT06274788

This study will demonstrate safety in pediatric patients with Parenteral Nutrition-Associated Cholestasis treated with Omegaven®, which is indicated as a source of calories and fatty acids in this patient population

Parenteral Nutrition Associated Liver Disease (PNALD)Essential Fatty Acid DeficiencyMalnutrition+1 more

Fresenius Kabi40 participantsStarted Dec 2024

Fountain Valley, California, United States • Los Angeles, California, United States • Chicago, Illinois, United States +7 more locations

International Rare Brain Tumor Registry

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Find Trials by Condition in Los Angeles

Expanded Access Program for Revumenib

Investigating the Tolerability of Oat Fiber (BG-OS) in Healthy Individuals

Adolescent Acts of Kindness Intervention With Reflection

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma

Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia

A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

CREST-2 Long-term Observational Extension Study

A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment

A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep

A Study of MORAb-202 in Participants With Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC) Adenocarcinoma (AC)

Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

Skin Reactions Related to Thoracic Implantable Chamber Dressings